CINtec+ Immunocytochemistry – a dual predictive screening test – to assess the risk of cervical precancerous conditions
CINtec+ immunocytochemistry is performed on all women who:
– Low-grade cervical epithelial neoplasia (CIN2) was detected
– High-risk types of HPV human papillomavirus identified
The test evaluates the condition of the cervical epithelium,
This allows for invasive diagnostic procedures to be scheduled only when necessary.
Book a gynecologist consultation at any of our Synevo branches and get cervical cancer screening.
CINtec+
Gynecologist consultation
Follow our social pages and learn more
